South Korea has emerged as the world leader in hair loss cosmetic innovation, outpacing other major economies in both research and patent activity over the last two decades.

According to the Korean Intellectual Property Office (KIPO), South Korea accounted for 42.9% of all global patent filings for hair loss cosmetics between 2002 and 2023. This puts the country well ahead of Japan (20.2%), the United States (17.2%), China (8.9%), and Europe (7.7%). The focus of these patents includes products like shampoos and ampoules that aim to prevent hair loss by regulating hormones, improving scalp circulation, or strengthening hair roots.

Innovation Driven by Culture and Science

South Korea’s leadership is fueled by a beauty-conscious culture and a strong social emphasis on hair health, as well as a willingness to innovate using both modern biotechnology and traditional remedies. Many patented ingredients are inspired by ancient medicinal texts such as Donguibogam, blending heritage with cutting-edge science.

Key Industry Players

The biotech company Caregen leads in patent applications with 115 filings, followed by Amorepacific with 72, and LG Household & Health Care with 25. South Korea also leads in patents for natural and bio-based ingredients, reflecting a trend toward safer and more sustainable solutions for hair loss.

Looking Ahead

With the hair loss cosmetics market projected to reach $26 billion globally by 2025, South Korea’s innovative edge positions it at the forefront of this rapidly growing industry. As research continues, consumers worldwide can expect to see more advanced and effective hair loss solutions emerging from Korean labs.


Sources:

  • South Korea tops global rankings in hair loss cosmetic innovation. The Monodist, March 2025.
  • South Korea leads patent filings on hair loss cosmetics, Japan and China follow. Asia IP, March 20, 2025.
author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.